Program

Chantal Csajka, PhD obtained her PharmD degree from the University of Lausanne in 1993, followed by her PhD in Clinical Pharmacology and Toxicology at the same university in 2000. In 2005 she received a postdoctoral fellowship in population pharmacokinetic-pharmacodynamic modeling at the University of California, San Francisco.
 
Dr. Csajka is currently working as research unit leader at the department of Clinical Pharmacology and Toxicology of the University Hospital Center of the Canton of Vaud and as senior scientist of the department of pharmaceutical Sciences of the University of Geneva and Lausanne in Switzerland.
 
Dr. Csajka’s field of interest is population pharmacokinetic modeling of pharmaceutical agents. Her recent and main current research includes investigations on antiretroviral drugs pharmacokinetics to provide a better understanding of sources of variability. In particular, several collaborative projects on the pharmacokinetic-pharmacogenetic modeling of antiretroviral drugs are conducted to investigate the contribution of genetic variations in drug absorption, distribution, metabolisation or elimination. Apart for HIV pharmacotherapy, her group is involved in the pharmacokinetic modeling of antibacterial, onchologic, antimalarials and psychotropic drugs that seeks at characterizing drug profile and source of variability and at providing dosage adjustment recommendations based on Bayesian feed-back strategies. Dr. Csajka’s related professionals activities concern teaching and consulting for academic and private institutions.